E-commerce and Physical Stores to Stock Hanmi’s OTC Drugs Following Shanghai Pharma Deal

Hanmi Pharmaceutical, a leading South Korean pharmaceutical company, has reportedly entered into a supply agreement with Shanghai Pharma Health Science, a subsidiary of Shanghai Pharmaceutical Group (SHA: 601607). The contract covers the distribution of seven OTC medications, which are planned to be initially marketed through Shanghai Pharma’s e-commerce platform, prior to their introduction in a physical pharmacy store located in Hong Kong. The financial details of the agreement have not been disclosed to the public. – Flcube.com